Western States Workgroup Recommends Johnson & Johnson COVID-19 Vaccine, Distribution Begins Statewide

Following the U.S. Food & Drug Administration’s (FDA) issuance of an emergency use authorization (EUA) of the Janssen Biotech, Inc. single-dose Johnson & Johnson COVID-19 vaccine last Saturday, the Western States Scientific Safety Review Workgroup met early this week to review the vaccine’s safety and efficacy data. The Workgroup completed its review of the available data and notified the governors of California, Nevada, Oregon, and Washington on Tuesday evening of its unanimous recommendation that the Johnson & Johnson vaccine is safe and effective against COVID-19.

Following the Workgroup’s review, the Johnson & Johnson vaccine became the third COVID-19 vaccine supported for use in the western states. Initial shipments of the single-dose vaccine were distributed throughout the state this week.

Additional information, including statements from western states governors, is available here.